Engelsk titel: Better regulatory framework needed for medical devices
Läs online
Författare:
Sjögren, Petteri
;
Sjövall, Henrik
Email: henrik.sjovall@medfak.gu.se
Språk: Swe
Antal referenser: 3
Dokumenttyp:
Artikel
UI-nummer: 16047238
Sammanfattning
We summarize an HTA report regarding patient values of drug-eluting stents and balloons for treatment of atherosclerotic
disease in the lower extremities. We found 17 randomized controlled trials, 4 cohort studies and 13 case series. The total
number of studied patients was substantial (about 3,000) but there was a strong heterogeneity regarding site of lesion, symptom
pattern, device, drug used and outcome measures, making the analysis difficult and based on relatively small subgroups. We
found low certainty of evidence (GRADE ++) for a reduced risk of restenosis in patients with critical ischemia and lesions below
the knee, and also a modest beneficial effect on ischemic symptoms in a mixed patient population. However, we also identified a
worrying safety signal, with increased risk for amputation in a group of patients with below-the-knee disease and critical
ischemia. The results highlight the need for a structured system for validation of medical devices, a system analogous to that
currently used for evaluation of new pharmacological products.